Diabetes Technology

Latest News

Telemedicine Care May Improve Management of Patients With Type 1 Diabetes

By

Amit Akirov, MD

Researchers explored the effects of a telemedicine visit on care in patients with T1D.

Intermittently Scanned CGM May Reduce Hypoglycemia in T1D

Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes.

ADA 2020 Standards of Care Incorporate CVD Risk Stratification, New Medications

By

Rachael Beairsto

The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.

Closed-Loop System Better Controls Blood Glucose Than Sensor-Augmented Insulin Pump

By

Amit Akirov, MD

A closed-loop insulin delivery system, also referred to as an artificial pancreas, was found to be more effective than sensor-augmented insulin pump therapy in patients with type 1 diabetes.

Fast-Acting Insulin Approved for Use in Insulin Infusion Pumps

By

Brian Park, PharmD

The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 diabetes.

Comparison of Faster vs Standard Insulin Aspart in Fully Closed-Loop Insulin Therapy

By

Amit Akirov, MD

There were no clear benefits of using faster insulin aspart in closed-loop insulin therapy and the closed-loop algorithm was better adjusted to the use of standard insulin aspart.

FDA: Insulin Pumps Could Be Hacking Targets

Medical devices that can connect to the internet might be at risk for hacking, the U.S. Food and Drug Administration warned Tuesday.

Examining Potential Allergens in Adhesives Used for Diabetes Devices

By

Tyler Rice

Colophonium, a fast-acting adhesive and known sensitizing allergen, may cause dermatologic reactions in children using devices to manage diabetes.

Use of Insulin Pump Therapy, CGM Increasing in Type 1 Diabetes

Highest rates reported among preschoolers, children, and adolescents aged younger than 15 years

Real-World Data Show Implantable Glucose Sensor Is Safe, Effective in First Commercial Users

By

Morgan E. Meissner

Real-world usage of an implantable continuous glucose monitoring system shows promise for improved glycemic control, sensor accuracy, and safety.

FDA Approves HbA1c Monitoring Device With Discreet Blood Sample Collection

By

Steve Duffy

The FDA has granted 510(k) market clearance to the OneDraw A1C Test system, which monitors HbA1c levels in individuals with diabetes for long-term glucose control.